Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

þQuarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for quarterly period ended June 30, 2018.

 

oTransition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from __________ to __________.

For the quarterly period ended September 30, 2022

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______________ to __________

 

Commission file number:   000-33467number: 000-1144546

 

FICAAR, INCHFactor, Inc.

(Exact name of registrant as specified in its charter)

 

Georgia 58-2634747
(State or other jurisdiction of incorporation)
incorporation or organization)
 (IRSI.R.S. Employer
Identification No.)

244 Madison Ave, #1249

New York, NY10016

(Address of principal executive offices)

(917)765-5977

(Registrant’s telephone number, including area code)

(Former name or former address, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

 

257 VaretTitle of ClassTrading Symbol(s)Name of each exchange on which registered/
Brooklyn, New York 11206HFactor, Inc. Common Stock
(Address of principal executive offices) (Zip Code)HWTROTC Markets: PINK

 

Securities registered pursuant to Section 12(g) of the Act:

Common Stock

(Title of Class)

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐  No ☒

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐  No ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to thesuch filing requirements for the past 90 days. Yesþ  No o

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of RegulationRegulations S-T (§232.405(232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yeso  No o

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of Registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer,”filer”, “smaller reporting company” and “emerging growth company” in rule 12b-2 of the Exchange Act.

 

Large accelerated filer oAccelerated filer
Non-accelerated filerSmaller reporting companyo
Non-accelerated fileroEmerging growth companyþ
Accelerated filero Emerging Growth Company

 

If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act. o

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. Yes ☐  No ☒

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).: Yes o☐  Noþ

 

As of October 15, 2018, there were 44,093,276November 19, 2022 the Registrant had 48,151,164 issued and outstanding shares of the Company’ s common stock.

 

 

 

FICAAR, INC.

HFactor, Inc.

FORM 10-Q

 

TABLE OF CONTENTS

  

PART I. FINANCIAL INFORMATION
   
Item 1.Financial Statements3
Item 1.2.Financial Statements3
Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations1120
Item 3.Quantitative and Qualitative Disclosures about Market Risk1624
Item 4.Controls and Procedures1624
 
PART II. OTHER INFORMATION  
   
PART II. OTHER INFORMATION
 
Item 1.Legal ProceedingsLegal Proceedings1725
Item1A.Item 1A.Risk FactorsRisk Factors1725
Item 2.Unregistered Sales of Equity Securities and Use of Proceeds1725
Item 3.Defaults Upon Senior Securities1725
Item 4.Mine Safety Disclosures1725
Item 5.Other InformationOther Information1725
Item 6.Exhibits1826
   
 Signatures1927

 

 Page 2 

 

PART I. FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

FICAAR,HFACTOR, INC.

(A development stage enterprise)

Condensed Consolidated Balance Sheets

 

     
 June 30, December 31,  September 30, December 31, 
 2018  2017  2022  2021 
 -Unaudited-     -Unaudited-  -Audited- 
             
ASSETS                
                
Current Assets                
Cash $-  $-  $22,036  $250,854 
Accounts receivable, net of allowance for doubtful accounts  157,120   75,737 
Inventories  393,683   468,913 
Prepaid expenses and other current assets  142,795   53,085 
        
Total Current Assets  715,634   848,589 
        
Fixed Assets, net of accumulated depreciation  208,807   257,219 
Intangible Asset, net of accumulated amortization  703,083    
                
Total Assets $-  $-  $1,627,524  $1,105,808 
                
LIABILITIES AND STOCKHOLDERS' DEFICIT                
                
Current Liabilities                
Accounts payable and accrued expenses $9,862  $12,830  $3,258,354  $3,097,807 
Accrued Interest  11,629   9,647   339,437   212,108 
Advances payable -officer  485   425 
Current portion of notes payable-third party, net of debt discount  841,908   463,221 
Notes payable-related party  741,641   641,641 
Government loans payable  160,000   160,000 
Derivative liabilities  801,449   793,997 
Warrant liability, net of unamortized discount     335,651 
                
Total Current Liabilities  21,976   22,902   6,142,789   5,704,425 
                
Long-Term Liabilities                
Note payable - Third party  57,734   44,234       
Note payable - Related party  6,525   6,525       
                
Total Long-Term Liabilities  64,259   50,759       
                
Total Liabilities $86,234  $73,661   6,142,789   5,704,425 
                
Commitments and Contingencies  -   -       
                
Stockholders' Deficit                
Preferred stock 10,000,000, $.001 par value shares        
authorized, no shares issued and outstanding        
Common stock 200,000,000, $.001 par value shares        
authorized; 44,093,276 shares issued and outstanding at  44,093   44,093 
June 30, 2018 and December 31, 2017        
Preferred stock 219,000,000, $.001 par value shares authorized, shares issued and outstanding as follows:        
Series C voting, convertible Preferred stock, $.001 par value 1,000,000 shares authorized; 1,000,000 shares issued and outstanding September 30, 2022 and December 31, 2021, respectively  1,000   10,003 
Series D non-voting, convertible Preferred stock, $.001 par value 18,000,000 shares authorized; 3,354 and 3,054 shares issued and outstanding September 30, 2022 and December 31, 2021, respectively  3   3 
Common stock 200,000,000, $.001 par value shares authorized; 48,151,164 and 47,631,164 shares issued and outstanding at September 30, 2022 and December 31,2021, respectively  48,151   47,631 
Common stock subscribed, 1,315,000 and 400,000 shares issued and outstanding at September 30, 2022 and December 31,2021, respectively  1,315   400 
Additional paid-in capital  (44,093)  (44,093)  (704,327)  (2,873,543)
Accumulated deficit  (86,234)  (73,661)  (3,861,407)  (1,774,108)
                
Total Stockholders' Deficit  (86,234)  (73,661)  (4,515,265)  (4,598,617)
                
Total Liabilities and Stockholders' Deficit $-  $-  $1,627,524  $1,105,808 

 

Going Concern (Note 2)

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

Page 3

FICAAR, INC.

(A development stage enterprise)

Condensed Consolidated Statement of Operations

  For The  For The  For The  For The 
  Three Months  Three Months  Six Months  Six Months 
  Ended  Ended  Ended  Ended 
  June 30, 2018  June 30, 2017  June 30, 2018  June 30, 2017 
   -Unaudited-   -Unaudited-   -Unaudited-   -Unaudited- 
                 
Revenues $-  $-  $-  $- 
                 
Operating expenses:                
Other operating expenses  2,310   2,060   6,592   2,710 
Professional fees:                
Audit fees  2,000   -   4,000   - 
Research and development  -   -   -   - 
Total expenses  4,310   2,060   10,592 �� 2,710 
                 
Loss from operations  (4,310)  (2,060)  (10,592)  (2,710)
                 
Interest expense  (996)  (548)  (1,981)  (1,090)
                 
Net loss $(5,306) $(2,608) $(12,573) $(3,800)
                 
Net Loss per common shares outstanding-Basic and dilutued:                
Net Loss per share attributable to common stockholders $(0.0001) $(0.0001) $(0.0003) $(0.0001)
                 
Weighted average shares outstanding  44,093,276   44,093,276   44,093,276   44,093,276 

The accompanying notes are an integral part of these condensed consolidated financial statements.

Page 4

FICAAR, INC.

(A development stage enterprise)

Condensed Consolidated Statement of Cash Flows

  Six Months  Six Months 
  Ended  Ended 
  June 30, 2018  June 30, 2017 
  -Unaudited-  -Unaudited- 
       
OPERATING ACTIVITIES:        
Net loss $(12,573) $(3,800)
Adjustments for changes in working capital:        
Accounts payable and accrued expenses  (2,968)  2,600 
Accrued interest  1,982   1,090 
Advances payable-officer  60   110 
         
Net cash (used ) in operating activities  (13,500)  - 
         
FINANCING ACTIVITIES:        
Proceeds from borrowing  13,500   - 
         
 Cash flows from financing activities  13,500   - 
         
Increase (decrease) in cash and cash equivalents  -   - 
         
Cash and cash equivalents - Beginning  -   - 
         
Cash and cash equivalents - Ending $-  $- 
         
Supplemental disclosures:        
Cash paid for interest $-  $- 
Cash paid for income taxes $-  $- 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

 Page 3

HFACTOR, INC.

Condensed Consolidated Statements of Operations

-Unaudited-

             
  Three Months  Three Months  Nine Months  Nine Months 
  Ended  Ended  Ended  Ended 
  September 30, 2022  September 30, 2021  September 30, 2022  September 30, 2021 
REVENUES                
                 
Sales, net $272,329  $513,174  $1,468,447  $513,174 
                 
TOTAL REVENUES  272,329   513,174   1,468,447   513,174 
                 
COST OF REVENUES  161,877   246,307   704,272   246,307 
                 
GROSS PROFIT  110,452   266,867   764,175   266,867 
                 
OPERATING EXPENSES                
Manufacturing expenses  71,356   41,726   159,720   41,226 
Sales and marketing  375,824   358,270   1,445,291   358,270 
General and administrative  149,832   233,810   735,013   247,168 
                 
Total Expenses  597,012   633,806   2,340,024   646,664 
                 
Loss from Operations  (486,560)  (366,939)  (1,575,849)  (379,797)
                 
Other (income) expense                
Amortization of debt discount  72,420   346,478   383,426   387,996 
Change in Fair Market Value of derivatives     124,406   7,452   124,406 
Derivative (income) expense     (314,665)     (97,654)
Interest expense  66,830   50,851   157,472   57,411 
Gain on forgiveness of debt     (113,799)     (113,799)
Other (income ) expense  (814)  3,233   (36,900)  (19,249)
                 
Total Other (income) expense  138,436   96,504   511,450   339,111 
                 
Net Loss $(624,996) $(463,443) $(2,087,299) $(718,908)
                 
Net Loss per common shares outstanding - Basic and diluted:                
Net Loss per share attributable to common stockholders $(0.0130) $(0.0072) $(0.0434) $(0.0142)
                 
Weighted Average Shares Outstanding  48,151,164   64,225,201   48,070,608   50,803,918 

The accompanying notes are an integral part of these condensed consolidated financial statements.

4

HFACTOR, Inc.

Consolidated Statements of Stockholders' Deficit

-Unaudited-

                                         
                         
  Series C  Series D        Common Stock  Additional       
  Preferred Stock  Preferred Stock  Common Stock  Subscribed  Paid-In  Accumulated    
  Shares  Amount  Shares  Amount  Shares  Amount  Shares  Amount  Capital  Deficit  Total 
                                  
Balance as of December 31, 2020   $    $  44,093,276  $44,093    $  $(44,093) $(181,415) $(181,415)
                                         
Net loss for the 3 months ended March 31, 2021                         (9,234)  (9,234)
                                         
Balance as of March 31, 2021           44,093,276   44,093        (44,093)  (190,649)  (190,649)
                                         
Net loss for the 3 months ended June 30, 2021                         (246,231)  (246,231)
                                         
Balance as of June 30, 2021           44,093,276   44,093        (44,093)  (436,880)  (436,880)
                                         
Net loss for the 3 months ended September 30, 2021                         (463,443)  (463,443)
                                         
Balance as of September 30, 2021   $    $  44,093,276  $44,093    $  $(44,093) $(900,323) $(900,323)
                                         
                                         
                                         
Balance as of December 31, 2021 1,000,000  $1,000  3,054  $3  47,631,164  $47,631  400,000  $400  $(2,873,543) $(1,774,108) $(4,598,617)
                                         
Sale of common shares           325,000   325  45,000   45   369,630      370,000 
Issuance of subscribed shares           400,000   400  (400,000)  (400)         
Cancellation of shares           (400,000)  (400)       400       
Cancellation of warrants in exchange for preferred stock      200                335,651      335,651 
Net loss for the 3 months ended March 31, 2022                         (806,873)  (806,873)
                                         
Balance as of March 3, 2022 1,000,000   1,000  3,254   3  47,956,164   47,956  45,000   45   (2,167,862)  (2,580,981)  (4,699,839)
                                         
Sale of common shares           150,000   150        149,850      150,000 
Issuance of preferred and subscribed shares      100     45,000   45  (45,000)  (45)         
Cancellation of shares                             
Net loss for the 3 months ended June 30, 2022                         (655,430)  (655,430)
                                         
Balance as of June 30, 2022 1,000,000   1,000  3,354   3  48,151,164   48,151        (2,018,012)  (3,236,411)  (5,205,269)
                                         
Sale of common shares                600,000   600   599,400      600,000 
Shares issued for purchase of Intellectual Property                715,000   715   714,285      715,000 
Net loss for the 3 months ended September 30, 2021                         (624,996)  (624,996)
                                         
Balance as of September 30, 2021 1,000,000  $1,000  3,354  $3  48,151,164  $48,151  1,315,000  $1,315  $(704,327) $(3,861,407) $(4,515,265)

The accompanying notes are an integral part of these condensed consolidated financial statements.

5 

 

FICAAR,

HFACTOR, INC.

Condensed Consolidated Statements of Cash Flows

-Unaudited-

       
  Nine Months  Nine Months 
  Ended  Ended 
  September 30, 2022  September 30, 2021 
       
OPERATING ACTIVITIES:        
Net loss $(2,087,299) $(718,908)
Adjustments to reconcile net loss to net cash used in operating activities:        
Amortization and Depreciation  60,565   21,332 
Amortization of debt discount on convertible notes  383,426   387,996 
Change in fair market value of derivative liabilities  7,452   124,406 
Derivative expense     (97,654)
Gain on forgiveness of debt     (113,799)
Changes in operating assets and liabilities:        
Accounts receivable  (81,383)  69,096 
Inventory  75,230   (825)
Prepaid expenses  (89,710)  (8,301)
Accounts payable and accrued expenses  155,572   176,624 
Accrued interest  127,329   49,233 
NET CASH PROVIDED BY (USED) IN OPERATING ACTIVITIES  (1,448,818)  (110,800)
         
CASH FLOWS FROM INVESTING ACTIVITIES:        
Equipment purchase      
NET CASH PROVIDED BY (USED) IN INVESTING ACTIVITIES      
         
FINANCING ACTIVITIES:        
Sales of common stock  1,120,000    
Proceeds from convertible notes payable     152,000 
Proceeds from Loans Payable, related Party  100,000    
Loan receivable     (3,000)
NET CASH PROVIDED BY (USED) IN FINANCING ACTIVITIES  1,220,000   149,000 
         
Increase (decrease) in cash and cash equivalents  (228,818)  38,200 
         
Cash and cash equivalents - Beginning  250,854    
         
Cash and cash equivalents - Ending $22,036  $38,200 
         
Supplemental Disclosure of Cash Flow Information        
Cash paid for interest $30,143  $ 
Cash paid for income taxes $  $ 
         
NON-CASH TRANSACTIONS:        
Common stock and Preferred stock issued in merger in exchange for net assets of HyEdge, Inc. $  $3,457,668 
Preferred stock issued in exchange for cancellation of Warrant Liabilities, net of unamortized discount $335,651  $ 
Common stock subscribed in exchange for assignment of Intellectual Property $715,000  $ 

The accompanying notes are an integral part of these condensed consolidated financial statements.

6

HFACTOR, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

NOTE 1 - DESCRIPTION OF BUSINESS

 

History

 

HFactor, Inc. formerly known as Ficaar, Inc. (the "Company"“Company” or "Ficaar"“Ficaar” or “HFactor”) was incorporated in July 2001 under the name OwnerTel, Inc. The name of the Company was changed to Ficaar, Inc. in December of 2007.2007 and to HFactor, Inc. on November 8, 2021.

  

The Company operates its business through its wholly owned subsidiary, Standard Canna, Inc. ("Standard"On May 28, 2021, David Cicalese (“Cicalese”), a Florida corporation formed in 2014,an officer and its wholly owned subsidiaries, Standard Cultivation Systems Inc., a Colorado corporation formed in 2014; and Standard Property Group Inc., a California corporation formed in 2014; as well as Precious Holdings, Inc. which was formed in April of 2011 in the state of Delaware and is wholly owned by the Company.

In August 2012, certain shareholders of the Ficaar (the "Shareholders"), representing a majority of the issued and outstanding common stockBoard member of Ficaar entered into an agreement with Gail Levy whereby Cicalese agreed to sell 29,900,000 shares, representing a majority interest in Ficaar, to Levy. Acting as the majority shareholder of the Company, Levy then caused Ficaar to enter into an Agreement and consummated such agreement with Sneaker Charmz,Plan of Merger (the “Merger Agreement”) between the Company, FCAA Merger Sub I, Inc. (“Merger Sub”), a Delaware corporation whereby 72,020,000 shares of common stockand wholly owned subsidiary of Ficaar, was assigned byand HyEdge, Inc. (“Target” or “HyEdge”), a Delaware corporation, wherein Merger Sub and Target would merge, with Target surviving the Shareholders to Sneaker Charmz. Thereafter, Sneaker Charmz, Ficaar and David Cicalese consummated a transaction where the shares of common stock of Ficaar owned by Sneaker Charmz were transferred and assigned to Mr. Cicalese and Mr. Cicalese transferred his ownership of Sneaker Charmz to Ficaar. Thus, Sneaker Charmz becameas a wholly owned subsidiary of Ficaar (the “Merger”). The Merger Agreement was executed on August 6, 2021 and Mr. Cicalese owns 85%the Merger closed on August 9, 2021. The Merger effected a change in control and was accounted for as a "reverse acquisition" whereby Target is the accounting acquiror for financial statement purposes. Accordingly, for all periods subsequent to the Closing Date, the financial statements of the total issuedCompany reflect the historical financial statements of HyEdge and outstanding common stockany operations of Ficaar. In addition, the Company divested Medical Cannabis Network, Inc., a company incorporated pursuantsubsequent to the laws of Delaware and Ficaar's former wholly-owned subsidiary. Mr. Jason Draizin resigned as an officer and member of Ficaar's board of directors and Mr. David Cicalese (President and sole member ofMerger.

Immediately following the Board of Directors of Sneaker Charmz) was appointed as President and a member of the Board of Directors of Ficaar. Following the consummation of the Agreement, Ficaar is engaged inMerger, the business of Sneaker Charmz,HyEdge became the development, marketing and sales of designer charms for footwear.

In January 2014, Mr. David Cicalese, President, a memberbusiness of the Board of Directors and majority shareholder of Ficaar, contributed 100 shares of Precious Holdings, Inc., a Delaware corporation, which consists of all of the issued and outstanding equity of Precious Holdings, Inc. Thus, Precious Holdings Inc. became a wholly owned subsidiary of the Company.

On November 16, 2014, we acquired 100% of the outstanding common stock of Standard Canna, Inc. ("Standard"), a Florida corporation, and its wholly owned subsidiaries, Standard Cultivation Systems Inc., a Colorado corporation; and Standard Property Group Inc., a California corporation, in exchange for 110,000 shares of our common stock pursuant to a Transfer Agreement (the "Agreement"), by and among, the Company and Jonas Zetzel, sole shareholder of Standard.

In June 2015, the Board of Directors and shareholders representing a majority of the issued and outstanding common stock of the Company appointed Dawn Cames as President of the Company and a member of its Board of Directors

 

In connection with the reverse acquisition and recapitalization, all share and per share amounts have been retroactively restated. Since the transaction is considered a reverse acquisition and recapitalization, accounting guidance does not apply for purposes of presenting pro-forma financial information.

 

On September 2, 2021 the Company filed an amendment in its articles of incorporation to change its name to HFactor Inc. The Company was able to secure an OTC Bulletin Board symbol HWTR from Financial Industry Regulatory Authority (FINRA).

Present Operations

 

In connection with the transactions contemplated by the Agreement, the business of theThe Company operating through its wholly owned subsidiary, Standard, will concentrate onHyEdge, Inc., a Delaware Corporation, engages in the purchase, developmentmanufacturing, marketing, distribution and operationselling of acquiring and developing growing space and related facilities and leasing our facilities to marijuana growers and dispensary owners for their operations in jurisdictions where such operations are consistent with state and local law.HFactor® hydrogen infused drinking water.

Page 6

FICAAR, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)

(Unaudited)

 

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES

 

Principles of Consolidation and Basis of Presentation

 

The accompanying (a) condensed consolidated balance sheet at December 31, 2017,2021, has been derived from audited financial statements and (b) condensed consolidated unaudited financial statements as of JuneSeptember 30, 20182022 and 2017,2021, have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements, and should be read in conjunction with the audited consolidated financial statements and related footnotes included in our Registration StatementAnnual Report on Form 10-12G/A10K for the yearsyear ended December 31, 2017 and 20162021 (the “2017 Registration Statement”“2021 Annual Report”), filed with the Securities and Exchange Commission (the “SEC”) on August 7, 2018.April 14, 2022. It is management’s opinion, however, that all material adjustments (consisting of normal recurring adjustments), have been made which are necessary for a fair financial statementsstatement presentation. The condensed consolidated financial statements include all material adjustments (consisting of normal recurring accruals) necessary to make the condensed consolidated financial statements not misleading as required by Regulation S-X, Rule 10-01. Operating results for the three and six months ended JuneSeptember 30, 2018,2022, are not necessarily indicative of the results of operations expected for the year ending December 31, 2018.2022.

 

7

These condensed consolidated financial statements are presented in accordance with accounting principles generally accepted in the United States (“GAAP”) and are expressed in United States dollars. These consolidated financial statements include the accounts of FicaarHFactor Inc. and its wholly owned subsidiaries, all of which are inactive, Standard Canna, Inc., a Florida corporation, and its wholly owned subsidiaries, Standard Cultivation Systems Inc., a Colorado corporation; and Standard Property Group Inc., a California corporation; and as well as Precious Holdings,subsidiary, HyEdge, Inc., a Delaware corporation. All inter-company balances and transactions have been eliminated on consolidation.

   

Development Stage

The Company is in the development stage as defined in Financial Accounting Standards Board Accounting Standards Codification ("ASC") Topic 915, "Development Stage Entities." The fiscal year end is December 31.

The Company is a start-up venture with little or no operating history and has no revenues. In its development stages and infancy, the officers of the Company spent considerable time and effort in research and development in order to create a niche in the cannabis industry.

Going Concern

 

The financial statements have been prepared on a going concern basis, and do not reflect any adjustments related to the uncertainty surrounding the Company's development stage losses.Company’s recurring losses, working capital deficiency or accumulated deficit.

 

As of September 30, 2022, the Company had $22,036 in cash to fund its operations. The Company currently has no revenues and has incurred losses duringdoes not believe its development stage. As of June 30, 2018,current cash balance will be sufficient to allow the Company has yet to commence substantial operations. Infund its planned operating activities for the coursenext twelve months. The ability of its start-up activities, the Company has sustainedto continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses and expects to incur operating losses in 2018.until it becomes profitable. These principal factors raise substantial doubt concerning the Company'sCompany’s ability to continue as a going concern. Management has financed the Company'sCompany’s operations principally through government loans, third party loans and from its President who is also a principal shareholderrelated parties, and third part financing. through equity investments into the Company.

It is the Company'sCompany’s intent to continue to attempt to raise funds in this manner and to raise funds through the sale of equity securities until the Company attains profitability. However, management cannot provide any assurance that the Company will be successful in accomplishing any of its plans.

 

The ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plan described in the preceding paragraph and eventually secure other sources of financing and attain profitable operations. The accompanying financial statements do not include any adjustments that might be necessary if

Cash

For purposes of reporting cash flows, the Company is unableconsiders all short-term investments with an original maturity of three months or less when purchased to continue asbe cash equivalents. As of September 30, 2022 and December 31, 2021, the Company held a going concern.cash balance of $22,036 and $250,854, respectively.

Revenue Recognition

  

Revenue Recognitionfrom sales of the Company’s products is recorded when title and risk of loss have passed to the buyer and criteria for revenue recognition is met. The Company sells its products to individual consumers and resellers upon receipt of a written order. The Company has a limited return policy for defective items that requires that buyers give the Company notice within 30 days after receipt of the products. Due to the immaterial quantities of returned products historically, for the periods ended September 30, 2022 and 2021, the Company recognized revenue at the time of delivery without providing any reserve.

 

Accounts Receivable

Accounts receivable represents amounts due from the Company’s customers. The Company recognizes revenue when persuasive evidencemaintains an allowance for doubtful accounts for estimated losses inherent in its accounts receivable portfolio. In establishing the required allowance, management utilizes a specific customer identification methodology. Management also considers historical losses adjusted for current market conditions and the customers’ financial condition and the current receivables aging and current payment patterns. Account balances are charged off against the allowance after all means of an arrangement exists, servicescollection have been rendered,exhausted and the sales pricepotential for recovery is fixed or determinable,considered remote. The Company does not have any off-balance sheet credit exposure related to its customers. As of September 30, 2022 and collectibility is reasonably assured. To dateDecember 31, 2021, the Company has not generated any revenue.allowance for doubtful accounts were not material.

 

 Page 78 

 

 

FICAAR, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)

(Unaudited)Inventories

 

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES (continued)Inventories are stated at the lower of cost (on a first-in, first-out basis) or market value. The stated cost is comprised of finished goods of HFactor® hydrogen infused drinking water, its related raw material and spare parts for machinery. Reserves, if necessary, are recorded to reduce inventory to market value based on assumptions about consumer demand, current inventory levels and product life cycles for the various inventory items. These assumptions are evaluated annually and are based on the Company’s business plan and from feedback from customers and the product development team. As of September 30, 2022 and December 31, 2021, the inventory reserves were not material.

 

Fixed Assets

Fixed assets are stated at cost, less accumulated depreciation. Depreciation is provided principally on the straight-line method over the estimated useful lives of the assets, which is generally three to five years. The cost of repairs and maintenance is charged to expense as incurred. Expenditures for property betterments and renewals are capitalized. Upon sale or other disposition of a depreciable asset, cost and accumulated depreciation are removed from the accounts and any gain or loss is reflected in other income or expense.

The Company will periodically evaluate whether events and circumstances have occurred that may warrant revision of the estimated useful lives of fixed assets or whether the remaining balance of fixed assets should be evaluated for possible impairment. The Company uses an estimate of the related undiscounted cash flows over the remaining life of the fixed assets in measuring their recoverability.

Intangible Assets

On July 22, 2022, the Company entered into an Intellectual Property Assignment Agreement, with Gail Levy whereby the Company acquired the intellectual property related to its beverage production operations from HyEdge IP in exchange for 715,000 shares of Company Common stock. The acquired intellectual property was valued at $1.00 per share for total valuation of $715,000 and is being amortized over 10 years on a straight-line basis.

Advertising Costs

Advertising costs are expensed as incurred. Advertising costs for the periods ended September 30, 2022 and 2021 were $107,342 and $ -0-, respectively.

Income Taxes

The Company accounts for income taxes under ASC 740, Income Taxes. Under ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period, which includes the enactment date. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.

ASC 740 contains a two-step approach to recognizing and measuring uncertain tax positions. This first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount which is more than 50% likely of being realized upon ultimate settlement. The Company considers many factors when evaluating and estimating its tax positions and tax benefits, which may require periodic adjustments and which may not accurately anticipate actual outcomes.

9

Based on its evaluation, the Company has concluded that there are no significant uncertain tax positions requiring recognition in its financial statements. The Company's evaluation was performed for the tax years ended December 31, 2017 through 2021, The Company does not expect any changes in its unrecognized tax benefits in the current year.

The Company’s policy for recording interest and penalties related to unrecognized tax benefits is to record such expenses as a component of current income tax expense. As of September 30, 2022 and December 31, 2021, the Company has no accrued interest or penalties related to uncertain tax positions.

Use of Estimates

 

The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management evaluates these estimates and assumptions on a regular basis. Actual results could differ from those estimates.

  

Research and Development Expense

 

Costs related to research and development, which primarily consists of consulting for logo and packaging design, are charged to expense as incurred. The Company has notnot incurred any research and development for the threeperiods ended September 30, 2022 and six months ended June 30, 2018 and 2017.2021.

 

Basic and Diluted Net Loss Per Share

 

The Company computes net income (loss)loss per common share, in accordance with FASB ASC Topic 260, Earning perEarnings Per Share, formerly Statement of Accounting Standards SFAS No. 128, "Earnings per Share", which requires dual presentation of both basic and diluted earnings per share ("EPS") on the face of theshare. Basic income statement. Basic EPSor loss per common share is computed by dividing net income (loss) available to common shareholders (numerator) before and after discontinued operations,or loss by the weighted average number of common shares outstanding (denominator) during the period, including contingently issuable shares whereperiod. Diluted income or loss per common share is computed by dividing net income or loss by the contingency has been resolved. Diluted EPS gives effect to all dilutive potentialweighted average number of common shares outstanding, duringplus the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the numberissuance of common shares, assumed to be purchasedif dilutive, that could result from the exercise of outstanding stock options orand warrants. No potential dilutive common shares are included in the computation of any diluted per share amount when a loss is reported.

 

Income TaxesStock Based Compensation

 

The Company accountsapplies the fair value method of ASC 718, Compensation-Stock Compensation, in accounting for income taxes underits stock-based compensation. These standards state that compensation cost is measured at the grant date based on the value of the award and is recognized over the service period, which is usually the vesting period, if any. The Company uses the Black-Scholes option pricing model to determine the fair value of its stock, stock option and warrant issuance. The determination of the fair value of stock-based payment awards on the date of grant using an option-pricing model is affected by the Company’s stock price, as well as assumptions regarding a number of complex and subjective variables. These variables include the Company’s expected stock price, volatility over the term of the awards, actual employee exercise behaviors, risk-free interest rate and expected dividends.

Fair Value

FASB ASC 740 (formerly FASB 109) "Accounting820, Fair Value Measurements and Disclosures (“ASC 820”) establishes a framework for Income Taxes". Underall fair value measurements and expands disclosures related to fair value measurement and developments. ASC 740 deferred tax820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC 820 requires that assets and liabilities measured at fair value are recognizedclassified and disclosed in one of the following three categories:

Level 1 Quoted market prices for the future tax consequences attributable to differences between the financial statementidentical assets or liabilities in active markets or observable inputs;

Level 2 Significant other observable inputs that can be corroborated by observable market data; and

Level 3 Significant unobservable inputs that cannot be corroborated by observable market data.

10

The carrying amounts of existing assetscash, loan receivable, accounts payable and other liabilities, and their respective tax bases. Deferred tax assetsaccrued interest payable approximate fair value because of the short-term nature of these items.

The fair value of the Company’s debt approximated the carrying value of the Company's debt as of September 30, 2022 and liabilities are measured using enacted tax rates expected to apply to taxable incomeDecember 31, 2021. Factors that the Company considered when estimating the fair value of its debt included market conditions, liquidity levels in the yearsprivate placement market, variability in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assetspricing from multiple lenders and liabilitiesterm of a change in tax rates in recognized in income in the period which includes the enactment date.debt.

 

In June, 2006, the Financial Accounting Standards Board issued FASB Interpretation No. 48 (FIN 48), "Accounting for Uncertainty in Income Taxes" - An interpretation of FASB Statement No. 109 and codified under ASC 740. FIN 48 clarifies the accounting for uncertainty in income taxes recognized in an entity's financial statements in accordance with Statement of Financial Accounting Standards No. 109, "Accounting for Income Taxes". This interpretation prescribed a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax provision taken or expected to be taken in a tax return. In addition, FIN 48 provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosures and transition.

Based on its evaluation, the Company has concluded that there are no significant uncertain tax positions regarding recognition in financial statements. The Company's evaluation was performed for the tax years, ended December 31, 2017, 2016, 2015, 2014 and 2013 for US federal income tax and state income taxes, the years which remain subject to examination by major tax jurisdictions as of December 31, 2017.

Recent Accounting Pronouncements

 

We have considered all other recently issued accounting pronouncements during 20182022 and 20172021 and do not believe the adoption of such pronouncements will have a material impact on our consolidated financial statements.

 

NOTE 3 – FIXED ASSETS, NET

Fixed assets, net consist of the following:

Schedule of fixed assets, net      
  September 30,  December 31, 
  2022  2021 
Machinery and equipment $577,645  $577,645 
Construction in progress  3,089   3,089 
Less accumulated depreciation  (371,927)  (323,515)
Fixed assets net $208,807  $257,219 

Depreciation expense for the periods ended September 30, 2022 and 2021 was $48,648 and $35,705, respectively.

NOTE 4 – NOTES PAYABLE-THIRD PARTIES

Third party convertible notes payable consists of the following: 

Schedule of third party convertible notes payable      
  

September 30,

2022

  

December 31,

2021

 
Convertible promissory note with interest at 8% per annum, convertible into common shares at the lesser of: (i) a 50% discount to market price for the Company’s stock or (ii) $0.01 per share. Matures on June 30, 2022, net of unamortized discount of $-0- at September 30, 2022. (Note 9) $121,369  $80,394 
         
$250,000 convertible promissory notes with interest at 10% per annum, convertible into common shares at any time after 180 days at 30% discount to the lowest daily VWAP during the 10-day period immediately preceding conversion. Matures on May 27, 2022, unless earlier converted, net of unamortized discount of $-0- at September 30, 2022. (A) (D)  250,000   176,805 
         
$152,000 convertible promissory notes with interest at 10% per annum, convertible into common shares at any time after 180 days at 30% discount to the lowest daily VWAP during the 10-day period immediately preceding conversion. Matures on July 22, 2022, net of unamortized discount of $-0- at September 30, 2022. (B) (D)  152,000   71,875 
         
$252,000 convertible promissory notes with interest at 10% per annum, convertible into common shares at any time after 180 days at 30% discount to the lowest daily VWAP during the 10-day period immediately preceding conversion. Matures on October 4, 2022, net of unamortized discount of $2,770 at June 30, 2022. (C) (D)  249,230   60,098 
         
Unsecured promissory note for finder’s fee due with interest at 10% per annum, with monthly payments of $1,000. Matures May 1, 2022, or the earlier of the Company aggregate proceeds exceeding $1,000,000 from the sale of equity securities. This note is in default and the Company is pursuing discussions with the lender for its extension.  69,309   74,049 
         
Total Notes Payable-Third Parties $841,909  $463,221 

 Page 811 

 

 

FICAAR, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)

(Unaudited)

NOTE 3 - NOTES PAYABLE -THIRD PARTY

The(A) Includes a warrant for the right to purchase an additional 250,000 shares of Company has issuedCommon Stock, subject to adjustments for anti-dilution. Each Warrant is exercisable for a note with a principal balance due inperiod of five years from the amountdate of $57,734 and $44,234 asissuance at June 30, 2018 and December 31, 2017, respectively. payable at 8% interest and due June 30, 2020. The note is convertible to common stock at the lesser of: (i) a 50% discount to market; and (ii) $0.01an initial exercise price of $1 per share. AsThe exercise price is also subject to adjustment due to certain events, including stock dividends, stock splits and recapitalizations. In the event the Company files a registration statement with the Securities and Exchange Commission, the Maturity Date shall be the earlier of June 30, 2018, and December 31, 2017(i) May 27, 2022; or (ii) the date on which the Company has determined that thereraised at least $1,250,000 under a registration statement. Interest is no beneficial conversion feature sincepayable at the Maturity Date. This note is in default and the Company is pursuing discussions with the lender for its extension.

(B) Includes a warrant for the right to purchase an additional 300,000 shares of Company Common Stock, subject to adjustments for anti-dilution. Each Warrant is exercisable for a period of five years from the date of issuance at an initial exercise price of $0.55 per share. The exercise price is also subject to adjustment due to certain events, including stock dividends, stock splits and recapitalizations. In the event the Company files a registration statement with the Securities and Exchange Commission, the Maturity Date shall be the earlier of (i) July 22, 2022; or (ii) the date on which the Company has no quoted market valueraised at least $1,500,000 under a registration statement. Interest is payable at the Maturity Date. This note is in default and the Company is pursuing discussions with the lender for its extension.

(C) Includes a warrant for the right to purchase an additional 300,000 shares of Company Common Stock, subject to adjustments for anti-dilution. Each Warrant is exercisable for a period of five years from the date of issuance at an initial exercise price of $0.55 per share. The exercise price is also subject to adjustment due to certain events, including stock dividends, stock splits and recapitalizations. In the event the Company files a registration statement with the Securities and Exchange Commission, the Maturity Date shall be the earlier of (i) October 4, 2022; or other means(ii) the date on which the Company has raised at least $1,500,000 under a registration statement. Interest is payable at the Maturity Date

(D) On December 3, 2021, the Company entered into a Stock Purchase Agreement with Boot Capital LLC (“Boot”), lender for the three notes of (A), (B) and (C), whereby Boot agreed to determine market.retire all of its outstanding warrants (850,000 in total) in exchange for 200 shares of Series D Preferred stock. The Preferred stock shares were issued on March 29, 2022. Accordingly, the Warrant liability of $335,651 as of December 31, 2021 was written-off during the period ended June 30, 2022.

In accordance with ASC 470-20 “Debt with Conversion and Other Options”, the Company allocated $-0- and $654,000 of the derivative liability as discounts against the convertible notes for the period ended September 30, 2022 and year ended December 31, 2021, respectively. The discounts are being amortized to interest expense over the term of the notes using the straight-line method which approximates the effective interest method. The Company recorded $383,426 and $387,996 of interest expense pursuant to the amortization of the note discounts during the periods ended September 30, 2022 and 2021, respectively.

12

 

NOTE 4 - 5 – NOTES PAYABLE - RELATED PARTY

Notes payable to related parties consists of the following:

Schedule of notes payable related parties      
  September 30,
2022
  December 31,
2021
 
Secured Promissory Note – RP, dated September 30, 2019 Note accrues interest at 10 % per annum, due and payable on July 1, 2023 (A) $445,116  $445,116 
         
Secured Promissory Note – LK, dated September 30, 2019 Note accrues interest at 10 % per annum, due and payable on July 1, 2023 (A)  100,000   100,000 
         
Secured Promissory Note – C Lemen, dated July 23, 2020. Note accrues interest at 10% per annum, due and payable on July 1, 2023 (A)(B)  90,000   90,000 
         
Unsecured Loan – Shareholder, dated September 23, 2022, terms to be formalized  100,000    
         
Unsecured Promissory Note – DC, dated September 30, 2012. Note accrues interest at 7% per annum, due and payable on June 30, 2022  6,525   6,525 
         
Total Notes Payable-Related Party $741,641  $641,641 

(A)Secured by all of Company’s accounts receivable and inventory.

(B)Includes a five (5) year common stock warrant of common stock. Warrants equal to 1% of the principal loan divided by $0.414, exercisable at the fair market value on execution date.

NOTE 6 – GOVERNMENT DEBT

Economic Injury Disaster Loan

On June 2, 2020, the Company executed a secured loan with the U.S. Small Business Administration (SBA) under the Economic Injury Disaster Loan program in the amount of $150,000. The loan is secured by all tangible and intangible assets of the Company and payable over 30 years at an interest rate of 3.75 % per annum. Installment payments, including principal and interest, totaling $731.00 monthly, will begin thirty (30) months from the date of the Note, with first payments applied to accumulated accrued interest. As part of the loan, the Company also received an advance of $10,000 from the SBA. While the SBA refers to this program as an advance, it was written into law as a grant. This means that the amount given through this program does not need to be repaid.

Future maturities of government debt are as follows:

Schedule of future maturities of debt   
Period Ending September 30,   
2022 $ 
2023   
2024   
2025   
Thereafter  150,000 
Total Principal Payments $150,000 

13

NOTE 7 – DERIVATIVE LIABILITIES

 

The Company has issuedanalyzed the notes payable – related parties and convertible notes payable referred to in Notes 4 and 5 based on the provisions of ASC 815-15 and determined that the conversion options of the convertible notes qualify as embedded derivatives and required the recognition of derivative liabilities.

For the derivative instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then revalued at each reporting date and any resulting gain or loss is recognized as a note payablecurrent period charge to its' majority shareholderthe consolidated statements of operations. The Company estimates the fair value of the embedded derivatives using a Monte Carlo simulation valuation model that combines expected cash outflows with market-based assumptions regarding risk-adjusted yields, stock price volatility, probability of a change of control and Presidentthe trading information of our common stock into which the notes are convertible, as appropriate to value the derivative instruments at inception and subsequent valuation dates and the value is reassessed at the end of each reporting period, in accordance with FASB ASC Topic 815-15.

The aggregate fair value of derivative liabilities as of September 30, 2022 and December 31, 2021 amounted to $801,449 and $793,997, respectively. The assets or liability’s fair value measurement within the fair value hierarchy is based upon the lowest level of any input that is significant to the fair value measurement. The following table provides a principal balance duesummary of the assets that are measured at fair value on a recurring basis.

Schedule of asset measured at fair value             
  Consolidated
Balance
Sheet
  

Quoted
Prices in
Active
Markets for
Identical
Assets or
Liabilities

(Level 1)

  

Quoted
Prices for
Similar
Assets or
Liabilities in
Active
Markets

(Level 2)

  

Significant
Unobservable
Inputs

(Level 3)

 
Derivative Liabilities:                
September 30, 2022 $801,449  $  $  $801,449 
December 31, 2021 $793,997  $  $  $793,997 

The following table sets forth a summary of the changes in the amountfair value of $6,525the Company’s Level 3 financial liabilities that are measured at fair value on a recurring basis:

Summary of changes in fair value of liability      
  

Period Ended
September 30,

2022

  Year Ended
December 31,
2021
 
Beginning balance $793,997  $ 
Aggregate fair value of conversion features upon issuance     918,403 
Fair value of derivatives reclassified to equity      
Net transfer into level 3      
Fair value of warrants netted against common stock issued for stock      
Change in fair value of conversion features  7,452   (124,406)
Change in fair value of warrant and stock option derivative liabilities      
Ending balance $801,449  $793,997 

14

NOTE 8 – MERGER AND RELATED TRANSACTIONS

The Merger

On August 6, 2021, the Company, FCAA Merger Sub I, Inc, (‘Merger Sub”), a Delaware corporation and wholly owned subsidiary of Ficaar, and HyEdge, Inc. ("Target" or "HyEdge"), a Delaware corporation, entered into an Agreement and Plan of Merger (the "Merger Agreement") which closed on August 9, 2021 (the "Closing Date"). Pursuant to the terms of the Merger Agreement, Merger Sub merged with and into the Target and the separate corporate existence of Merger Sub ceased, with Target continuing its corporate existence as a wholly owned subsidiary of the Company. The Merger effected a change in control and was accounted for as a "reverse acquisition" whereby Target is the accounting acquiror for financial statement purposes. Accordingly, for all periods subsequent to the Closing Date, the financial statements of the Company reflect the historical financial statements of HyEdge and any operations of the Company subsequent to the Merger.

Prior to the Merger, the Company ceased being an operating company and became a "shell company". Pursuant to the Merger, the Company acquired the business of Target to engage in the business of the development, marketing, and sale of hydrogen-infused water and other consumer goods.

As consideration for the merger, Target shareholders exchanged 100% of Target Stock (as defined in the Merger Agreement) totaling 44,136,473 fully diluted shares into shares of Company Common Stock at a conversion rate of 0.7 As a result, an aggregate of 30,895,530 shares of the company’s Common Stock, 1,000,000 shares of Series C Preferred Stock and 3,054 shares of Series D Preferred Stock were to be issued to the shareholders of Target. As of December 31, 2021, there were 30,197,888 of the planned Merger shares of common stock issued and the Series C and D Preferred shares issued.

Changes to the Company's Officers and Directors

Effective May 27, 2021, the Company’s Board of Directors appointed Gail Levy as Chief Executive Officer of FICAAR, Inc. On June 30, 20181, 2021, in conjunction with the aforementioned change in control, David Cicalese resigned as Secretary and December 31,2017 payableChairman of the Board of Directors. On June 9, 2021, a majority of Company shareholders elected Gail Levy as Chairman and a member of the Board of Directors. These changes were reported on the Company's form 8-K that was filed on June 10, 2021.

In conjunction with the Merger, Dawn Cames resigned as President, James C. Sanborn was appointed as COO and as a member of the Board of Directors, and Leonard Klingbaum was appointed as a member of the Board of Directors.

On July 22, 2022, the Company entered into a Memorandum of Understanding (“MOU”) with Bear Face Capital LLC (“Bear Face”) and Concorde Consulting Corp (“Concorde”) for an influx of capital. In accordance with the terms of the MOU, the following changes were implemented: (i) Gail Levy resigned as Chief Executive Officer and assumed the position of President for the Company, subject to a two (2) year Employment Contract, renewable annually, at 7% interest maturing June 30, 2020.an annual salary of $120,000; (ii) Dawn Cames, former officer for the predecessor company (“FICAAR), was appointed to serve as a Director and Chairman of the Board for the Company and was assigned one (1) share of Series C Preferred stock; (iii) Gail Levy, James C. Sanborn, and Leonard Klingbaum resigned as members of the Board of Directors; (iv) James C. Sanborn resigned as COO; and (v) Gail Levy and James C. Sanborn returned 999,999 shares of Series C Preferred stock to the Company.

15

 

NOTE 5 - 9 – COMMITMENTS AND CONTINGENCIES

 

Legal

To the best of our knowledge and belief, no material legal proceedings of merit are currently pending or threatened.

 

Legal Matters:

From time to time, the Company may become involved in various lawsuits and legal proceedings, which arise in the ordinary course of business. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm its business.

To the best of the Company’s knowledge and belief, no material legal proceedings of merit are currently pending or threatened.

Dispute:

The Company is disputing the validity of a convertible promissory note carried over from its merger in August 2021. Since it presently is not possible to determine the outcome of this matter, the note is disclosed in Note 4 to the financial statements with a net balance of $121,369 until its ultimate resolution.

Employment and Consulting Agreements:

Gail Levy resigned as Chief Executive Officer and assumed the position of President for the Company, subject to a two (2) year Employment Contract, renewable annually, at an annual salary of $120,000

Rental:

As a result of the COVID-19 pandemic, Company management and employees have been working remotely and accordingly, incurring no rental expense during the years ended December 31, 2021, and 2020.

COVID-19

In December 2019, a novel strain of coronavirus (“COVID-19”) was reported to have surfaced in Wuhan, China, and has since reached multiple other countries, including the United States, resulting in government-imposed quarantines, travel restrictions and other public health safety measures in affected countries. The various precautionary measures taken by many governmental authorities around the world in order to limit the spread of COVID-19has had, and could continue to have, an adverse effect on the global markets and its economy, including on the availability and pricing of employees and resources, and other aspects of the global economy. Although the Company cannot predict the impact that the COVID-19 pandemic will have on its business or results of operations in future periods, to date, the Company’s core water product applications have been able to support the increased demand the Company has experienced.

On March 11, 2020, the World Health Organization declared the ongoing COVID-19 outbreak as a global health emergency. This resulted in governments worldwide enacting emergency measures to combat the spread of the virus, including the closure of certain non-essential businesses

During the years ended December 31, 2021, and 2020, respectively, the pandemic did not have a material impact on the Company’s operations. As of December 31, 2021, and 2020, and through September 30, 2022, the Company did not observe any material impairment of its assets or a significant change in the fair value of assets due to the COVID-19 pandemic. The Company has taken steps to minimize the potential impact of the pandemic including safety measures with respect to personal protective equipment, the reduction in travel and the implementation of a virtual office including regular video conference meetings and participation in virtual customer meetings and other virtual events.

16

NOTE 6 - 10 – EQUITY

 

Common stock:

The Company has authorized 200,000,000 shares of $.001$.001 par value common stock and asstock. As of JuneSeptember 30, 20182022, and December 31, 2017,2021, the Company had 44,093,27648,151,164 and 47,631,164 shares, respectively, of common stock issued and outstanding.

 

On October 27, 2021 26,910,000 shares of Common Stock of the Company held by the Company’s Chief Executive Officer were returned to treasury and retired.

On December 10, 2021 and December 15, 2021, the Company received total proceeds of $650,000 for the sale of 650,000 common stock shares at $1.00 per share. The December 15, 2021 sale of 400,000 shares were issued on January 3, 2022 and accordingly, recorded as common stock subscribed in the accompanying financial statements.

On November 12, 2021, the U.S. Securities and Exchange Commission (“SEC”) issued a Notice of Qualification for the Company's Form 1-A Offering Circular for an offering of the Company’s Common Stock shares under Regulation A+ (the "Offering") of the Securities Act of 1933 (the “Act”). The purpose of the Offering is to allow both accredited and non-accredited potential investors the opportunity to invest directly in the Company. The Offering has a minimum and maximum investment of $25,000 to at a price of $1.00 per share.

During the first quarter of 2022, the Company received total proceeds of $370,000 for the sale of 370,000 common stock shares at $1.00 per share, of which 45,000 shares were issued in the second quarter ending June 30, 2022 and accordingly, recorded as common stock subscribed in the accompanying financial statements.

During the second quarter of 2022, the Company received total proceeds of $150,000 for the sale of 150,000 common stock shares at $1.00 per share.

During the third quarter of 2022, the Company received total proceeds of $600,000 for the sale of 600,000 common stock shares at $1.00 per share, which as of date of the accompanying financial statements have not been issued and, accordingly recorded as common stock subscribed.

Preferred Stock:

The Company has authorized 10,000,00030,000,000 shares of $.001$.001 par value preferred stock. The

On August 6, 2021, the Company has no preferredamended its Articles of Incorporation to include Certificates of Designation for two new classes of Preferred Stock – Series C Preferred, authorized 1,000,000 shares and, Series D Preferred, authorized 18,000,000 shares.

In connection with the Merger with HyEdge, on September 15, 2021, the Company issued 1,000,000 shares of Series C Convertible Preferred stock, non-dividend, with voting rights. Each share of Series C Preferred stock is convertible into the number of shares of the Company’s common stock equal to the result of (i) 1.5 times the number of Common shares issued and outstanding.outstanding calculated on a fully diluted basis at the time of conversion, (ii) divided by the total number of Series C Preferred shares issued and outstanding at the time of conversion.

 

Additionally, the Company issued 3,054 shares of Series D Convertible Preferred stock, non-dividend, with no voting rights. Each share of Series D Preferred stock is convertible into the number of shares of the Company’s common stock equal to 0.01% of the number of Common shares issued and outstanding at the time of conversion.

On December 3, 2021, the Company entered into a Stock Purchase Agreement with Boot Capital LLC (“Boot”) whereby Boot Capital agreed to retire all of its outstanding warrants (850,000 in total) in exchange for 200 shares of Series D Preferred stock. The Preferred stock shares were issued on March 29, 2022.

On June 29,2022, 100 shares of Series D Preferred Stock were issued to an investor in connection with execution of a Leak-Out Agreement.

17

On July 28,2022, 250 and 350 shares of Series D Preferred Stock were issued to an two investors in connection with execution of a Leak-Out Agreements.

NOTE 7 - 11 – INCOME TAXES

 

The Company uses the liability method, where deferred tax assets and liabilities are determined based on the expected future tax consequences of temporary differences between the carrying amounts of assets and liabilities for financial and income tax reporting purposes. During the current period, the Company incurred a net loss and therefore has no tax liability.

 

The Company has U.S. federal and state net operating loss carryovers (“NOL’s”) of approximately $16 million and $13 million at September 30, 2022 and December 31, 2021, respectively, which begin to expire in 2036. Section 382 of the Internal Revenue Code limits the amount of NOL’s available to offset future taxable income when a substantial change in ownership occurs.

The significant components of deferred income tax assets at September 30, 2022 and December 31, 2021 were as follows: 

Schedule of Components of Deferred Income Tax Asset      
  

September 30,

2022

  

December 31,

2021

 
Deferred tax asset:        
Net operating loss carry-forward $3,800,000  $3,150,000 
Less: valuation allowance  (3,800,000)  (3,150,000)
         
Net deferred income tax asset $  $ 

The amount taken into income as deferred income tax assets must reflect that portion of the income tax loss carry forwards that is more-likely-than-not to be realized from future operations. The Company has chosen to provide a full valuation allowance against all available income tax loss carry forwards. The Company has recognized a valuation allowance for the deferred income tax asset since the Company cannot be assured that it is more likely than not that such benefit will be utilized in future years. The valuation allowance is reviewed annually. When circumstances change and which cause a change in management’s judgment about the realizability of deferred income tax assets, the impact of the change on the valuation allowance is generally reflected in current income.

NOTE 8 - 12 – RELATED PARTY TRANSACTIONS

 

Parties are considered to be related if one party has the ability to control or exercise significant influence over the other party in making financial and operating decisions. Details of transactions between the Company and related parties are disclosed below:

 

The following have been identified asOn April 15, 2019, the Company entered into an intellectual property licensing agreement (the “Agreement”) with HyEdge IP Co. (“HyEdge IP”), an entity 100% owned by the founder and CEO of the Company.  Pursuant to the agreement, HyEdge IP granted the Company an exclusive, non-assignable, non-sublicensable and royalty-free right and license to use the intellectual properties related parties:to beverages infused with hydrogen for human consumption owned by HyEdge IP (the “Intellectual Properties”), solely within North America. In addition, the Company agrees to irrevocably assign and transfer to HyEdge IP, all of its right, title and interest in and to any improvements, acquired through use, modification or improvement, on the Intellectual Properties (the “Improvements”). On July 22, 2022, the Company entered into an Intellectual Property Assignment Agreement, with Gail Levy whereby the Company acquired the intellectual property related to its beverage production operations from HyEdge IP in exchange for 715,000 shares of Company Common stock

  

David CicaleseDirector and greater 10% shareholder
Dawn CamesPresident
Concorde ConsultingHolder of convertible note of $57,734 as of June 30, 2018

The following balances existed with related parties:

 

  June 30,  December 31, 
  2018  2017 
       
Balance sheet:        
Advances Payable -officer $485  $425 
Accrued Interest $11,629  $9,647 
         
Income Statement        
Interest expense $1,981  $2,404 

 Page 918 

 

 

FICAAR, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)

(Unaudited)On December 20, 2019, the Company and HyEdge IP entered into an amendment to the Agreement (the "Amendment"), expanding the territory in the Agreement from North America to worldwide, including the World Wide Web. In addition, the Amendment clarified the scope of the license and rights in question, which includes the Intellectual Properties and the Improvements. The Amendment also stipulated that the Company and HyEdge IP shall agree upon a royalty for the Company's use of the Intellectual Properties, including the Improvements, outside of North America. 

 

NOTE 9 - RELATED PARTY TRANSACTIONS (continued)13 – SUBSEQUENT EVENTS

 

The President ofCompany has evaluated subsequent events through November 19, 2022, which is the company made payments on behalf ofdate the Company. On November 9, 2017, $18,110 of Advances Payablefinancial statements were issued, and has concluded that no such events or transactions took place which would require adjustment to an officer ofor disclosure in the Company and were subsequently reimbursed by the 3rd party holder of the Note Payable and added to its Note. Additionally, on December 31, 2017, $4,367 of Advances Payable to the Company’s attorney were reimbursed by the 3rd party holder of the Note Payable and added to its Note.financial statements.

 

 Page 1019 

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

This Management’s Discussion and Analysis (“MD&A”) is intended to provide an understanding of our financial condition, results of operations and cash flows by focusing on changes in certain key measures from year to year. This discussion should be read in conjunction with the Condensed Consolidated Unaudited Financial Statements contained in this Quarterly Report on Form 10-Q and the Consolidated Financial Statements and related notes and MD&A of Financial Condition and Results of operations appearing in our Registration StatementAnnual Report on Form 10-12G/A10-K as of and for the years ended December 31, 20172021 and 2016.2020. The results of operations for an interim period may not give a true indication of results for future interim periods or for the year.

 

Cautionary Statement Regarding Forward Looking Statements

 

This Quarterly Report on Form 10-Q, Financial Statements and Notes to Financial Statements contain forward-looking statements that discuss, among other things, future expectations and projections regarding future developments, operations and financial conditions. All forward-looking statements are based on management’s existing beliefs about present and future events outside of management’s control and on assumptions that may prove to be incorrect. If any underlying assumptions prove incorrect, our actual results may vary materially from those anticipated, estimated, projected or intended.  We undertake no obligation to publicly update or revise any forward-looking statements to reflect actual results, changes in expectations or events or circumstances after the date this Quarterly Report on Form 10-Q is filed.

 

When this report uses the words “we,” “us,” “our,” or “FICAAR” and the “Company,” they refer to Ficaar, Inc.

   

Company History and Summary

HFactor, Inc., formerly known as Ficaar, Inc. (the “Company” or “HFactor” or “Ficaar”) was incorporated in July 2001 in the State of Georgia under the name OwnerTel, Inc. The name of the Company was changed to Ficaar, Inc. in December of 2007 and to HFactor, Inc. on September 2, 2021.

The Company’s fiscal year end is December 31. 

On May 28, 2021, David Cicalese (“Cicalese”), an officer and Board member of Ficaar entered into an agreement with Gail Levy whereby Cicalese agreed to sell 29,900,000 shares, representing a majority interest in Ficaar, to Levy. Acting as the majority shareholder of the Company, Levy then caused Ficaar to enter into an Agreement and Plan of Merger (the "Merger Agreement") between the Company, FCAA Merger Sub I, Inc. ("Merger Sub"), a Delaware corporation and wholly owned subsidiary of Ficaar, and HyEdge, Inc. ("Target" or "HyEdge"), a Delaware corporation, wherein Merger Sub and Target would merge, with Target surviving the transaction as a wholly owned subsidiary of Ficaar (the "Merger"). The Merger Agreement was executed on August 6, 2021 and the Merger closed on August 9, 2021. The Merger effected a change in control and was accounted for as a "reverse acquisition" whereby Target is the accounting acquiror for financial statement purposes. Accordingly, for all periods subsequent to the Closing Date, the financial statements of the Company reflect the historical financial statements of HyEdge and any operations of the Company subsequent to the Merger.

Plan of Operations

 

Proposed ActivitiesBUSINESS DESCRIPTION

 

We areHFactor water was created by Gail Levy, HyEdge's founder and CEO. Gail is a successful serial entrepreneur who was looking for a new product that could alleviate the toxic side effects of the cancer chemotherapeutic drugs that had riddled a dear friend. As she researched the properties of hydrogen water, she became more and more enthralled by its potential. Ms. Levy felt she could honor her friend by making hydrogen water immaculate, effective, and accessible to everyone. Enlivened by this mission, she collected a team of experts to help her engineer a natural process to combine hydrogen with water with zero impurities and optimal impact. In 2017, she launched her flagship product through retail and ecommerce channels. HFactor was developed and is manufactured by a team of experts in the U.S. and utilizes a patented chemical-free and magnesium-free process of identifying properties for purchase in Colorado, Washingtonto infuse free hydrogen into its water. Its award winning, environmentally friendly ergonomic pouch keeps the hydrogen potent and California. These projects include the purchase of existing, currently operating facilities, as well as proposed new construction projects. With the assistance of our consultants, cannabis industry experts, we have developed specific criteria in terms of the suitability of existing structures as well as plans for new constructions projects.pure and makes it extremely portable.

 

More importantly with the assistance of our consultants, we have developed a fully scalable design model centered around maximizing yields and meeting the needs of cannabis cultivators which will be our tenants. We believe that the cornerstone of our model is maximizing yields by properly implementing cutting edge technology that will maintain an ideal controlled environment for our tenant cultivators. It is anticipated that each property will be remodeled, in the case of existing structures; and designed, in the case of new construction, to contain numerous independent growers.

 

Each space will be a full-scale commercial cultivating facility with bay door access, adequate flowering, vegetative growth and propagating space including but not limited to access to large areas for harvesting and state of the art curing chambers. Our security will be on premise 24 hours per day. An IT camera system will be operational monitoring the inside and outside of the facility. Our design model is fully scalable. We believe that the cornerstone of our model is maximizing yields by properly implementing cutting edge technology that will maintain an ideal controlled environment for our tenant cultivators. This begins with an advanced controlled environment that is protected from the 18 outside environment. Specialized HVAC systems will maintain a constant temperature, humidity, airflow and CO2 with precise controls. High intensity discharge lighting systems will provide the ideal environment for growing. An integrated irrigation system can be modified to each tenant’s specifications and requirements.

Our design model anticipates that our building will have “state of the art” security systems that will fully protect our tenant cultivator’s crops and property as well as allow our tenants to view and monitor their crops remotely. In addition, our tenant cultivators will have a fully secure ingress and egress to our facility. Our design model also features solar power system in order to be more cost efficient and provide less of a carbon footprint. Our design model will ensure that our tenant cultivators will maximize their yields.

Management is currently seeking to identify a suitable warehouse building in the county of Los Angeles, California to “test” the business model. The ideal location will have 10,000 square foot in an area properly zoned for cannabis cultivation. Management estimates that such a location may cost approximately $3,000,000.00. Management expects to locate a suitable location during the fiscal quarter ending September 30, 2018 and entering into a purchase agreement for such property.

 Page 1120 

 

 

ManagementHFactor's anti-inflammatory and antioxidant benefits appeal to a wide population across every age group, positioning HFactor to capture significant share in an expanding market. The global market for bottled water is projected to reach $215B by 2025. HFactor has been engageddemonstrated significant market traction, with $2.87M sales in discussions with private debt lenders with respect to the financing of the initial building locations. Although no agreements or commitments for such funding have been offered, Management believes that it will be able to obtain financing of the initial property; however, the terms of such financing will be less favorable than those offered to non-cannabis business due to the current state of Federal laws as set forth herein. Management believes that, assuming a suitable property is located and secured with a purchase agreement, the property purchase can be closed during the first quarter of 2019.2020, 30M+ followers across Social Media channels.

 

Upon the closing of the property purchase, the company will execute its build out pursuant to the business plans set forth above (i.e., dividing the property into separate leasable growing space for tenant cultivators; each leasable “unit” containing all of the necessary equipment and features for a full scale commercial cultivating facility; including but not limited to:

(i)HVAC systems that will maintain a constant temperature, humidity, airflow and CO2 with precise controls;
(ii)High intensity discharge lighting systems will provide the ideal environment for growing;
(iii)An integrated irrigation system; and
(iv)Security.

Management anticipates that the buildout of the property will take at least six (6) months following the date of the consummation of the purchase of the property. Prior to the consummation of the buildout of the property, Management anticipates hiring employees to manage the property and engage the tenant cultivators. Assuming a suitable property is located and secured with a purchase agreement and the property purchase is closed during the first quarter of 2019, the property will be ready to lease to tenant cultivators by the third quarter of 2019 which would generate the initial revenue of the Company. The company expects to utilize private funding sources to finance the build out of the property. No agreements or commitments for such funding have been offered. Management anticipates that it will need to provide security for the financing of the property and the buildout of the property by way of a mortgage on the property as well as a security agreement for the equipment purchased in the buildout.

We believe that implementing our design model in an existing building or new construction will be a complete solution for the professional cultivator. Our plans will be dependent upon our ability to raise the capital required to acquire properties and remodel or construct such properties. We also intend to offer to our tenant cultivators certain value-added services that will be provided at additional costs. Such services may include but certainly will not be limited to fertilizer, additives, vitamins, and grow consultants.

Generally, the ownership and operation of real properties are subject to various laws, ordinances and regulations, including regulations relating to zoning, land use, water rights, wastewater, storm water runoff and lien sale rights and procedures.

Zoning sets forth the approved use of land in any given city, county or municipality. Zoning is set by local governments or local voter referendum and may otherwise be restricted by state laws. For example, under certain state laws a seller of liquor may not be allowed to operate within 1,000 feet of a school. There are similar restrictions imposed on cannabis operators, which will restrict where cannabis operations may be located and the manner and size to which they can grow and operate. These zoning restrictions vary in each State, County, City and Township. Zoning can be subject to change or withdrawal, and properties can be re-zoned. The zoningquality of our properties will haveproduct is achieved through a direct impact on our business operations.

In addition, other laws, ordinances or regulations, such as the Comprehensive Environmental Responseproprietary manufacturing process. A reverse osmosis filtering system and Compensation Liability Actpatent-protected infusion process ensures efficacy, purity, and its state analogs, or any changes to any such laws, ordinances or regulations, could result in or increase the potential liability for environmental conditions or circumstances existing, or createdtaste. The efficacy of hydrogen water is backed by tenants or others, on our properties. Laws related to upkeep, safetyover 1,000 published peer reviewed studies demonstrating that hydrogen positively impacts fitness, health, lifestyle, recovery, and taxation requirements may result in significant unanticipated expenditures, loss of our properties or other impairments to operations, any of which would adversely affect our cash flows from operating activities.wellness.

 

Our property management activities,sales strategy involves a diversified, multi-channel approach. Our products are currently on shelves in approximately 5,000+ retail stores across 20 chains in addition to the extent we are required to engage in themour growing ecommerce presence. Our company prides itself on having a low carbon footprint, primarily due to lease defaults by tenants or vacancies on certain properties, will likely be subject to state real estate brokerage lawsour eco-conscious packaging and regulations as determined by the particular real estate commission for each state.

The properties that we acquire will be leased to tenant cultivators who will use their leased properties primarily for cultivation and production of cannabis and thus will be subject to the laws, ordinances and regulations of state, local and federal governments, including laws, ordinances and regulations involving land use and usage, water rights, treatment methods, disturbance, the environment, and eminent domain.

Page 12

In addition, state, local and federal governments also seek to regulate the type, quantity and method of use of chemicals and materials for growing crops, including fertilizers, pesticides and nutrient rich materials. Such regulations could include restricting or preventing the use of such chemicals and materials near residential housing or near water sources. Further, some regulations have strictly forbidden or significantly limited the use of certain chemicals and materials. Licenses, permits and approvals must be obtained from governmental authorities requiring such licenses, permits and approvals before chemicals and materials can be used at grow facilities. Reports on the usage of such chemicals and materials must be submitted pursuant to applicable laws, ordinances, and regulations and the terms of the specific licenses, permits and approvals. Failure to complyfree mail-in recycling program through our partnership with laws, ordinances and regulations, to obtain required licenses, permits and approvals or to comply with the terms of such licenses, permits and approvals could result in fines, penalties and/or imprisonment.

As an owner of the properties, we may be liable or responsible for the actions or inactions of our tenants with respect to these laws, regulations and ordinances.

The Company has purchased the following domain names (pursuant to the Purchase Agreement):

www.standardcanna.com

www.standardcultivation.com

www.standardgrow.comTeracycle.

 

Our Products, Servicesmission statement is to build a brand and Customers

corporate culture that, at its essence, exhibits strength in oneself and in one's community. We operate inpromote a rapidly evolvingfoundation of "doing well by doing good". This foundation enables HFactor to produce and highly regulated industrydistribute the highest quality "better for you" consumer products that as has been estimated by some, will exceed $30 billion in revenue by the year 2020.  We have been and will continue to be aggressive in executing acquisitions and pursuing other opportunities that we believe will benefit us in the long-term.

We plan to provide services and solutionsare conscious to the regulated cannabis industry throughoutcommunity, mind, body, and the United States by acquiring and developing growing space and related facilities and leasing areas within our facilities to marijuana growers and dispensary owners for their operations in jurisdictions where such operations are consistent with state and local. In exchange for certain services that may be provided to these tenants, we expect to receive rental income in the form of cash. In certain cases, we may acquire equity interests or provide debt capital to these businesses.environment

 

Comparison of Three Months Ended JuneSeptember 30, 20182022 to Three Months Ended JuneSeptember 30, 20172021

 

Results of Operations

 

  Three Months ended September 30,     Percent 
  2022  2021  Change  Change 
Revenues $272,329  $513,174  $(240,845)  (47)% 
Gross profit  110,452   266,867   (156,415)  (59)% 
Operating expenses  (597,012)  (633,806)  (36,794)  (6)% 
Other income (expense)  (138,436)  (96,504)  41,932   43% 
Net loss $(624,996) $(463,443) $(161,553)  35% 

Net revenues for the three months ended September 30, 2022 were $272,329 as compared to $513,174 for the three months ended September 30, 2021 which resulted primarily from higher distributor dictated trade spending during the summer high peak season.

  Three months ended June 30,     Percent 
  2018  2017  Change  Change 
Revenues $-  $-  $-   -%
Operating expenses  (4,310)  (2,060)  (2,250)  109%
Other expense-interest  (996)  (548)  (443)  81%
Net loss $(5,306) $(2,608) $(2,693)  103%

Gross profit for the three months ended September 30, 2022 was $110,452 as compared to $266,867 for the three months ended September 30, 2021.

Total operating expenses were $597,012 for the three months ended September 30, 2022 compared to $633,806 for the three months ended September 30, 2021. The 6% decrease was primarily attributable to a reduction in payroll and compensation.

Other income (expense) was $(138,436) for the three months ended September 30, 2022 compared to $(96,504) for the three months ended September 30,2021. The $41,932 increase was primarily additional interest accrued associated with convertible debt borrowings that are in default status.

 

For the three months ended JuneSeptember 30, 2018,2022, the Company reported a net loss of $5,306$624,996 as compared to a net loss of $2,608$463,443 for the three months ended JuneSeptember 30, 2017.2021. The 103%$161,553 increase in net loss for the three months ended JuneSeptember 30, 20182022 mainly resultedarose from $4,310 in general and administrative expenses relating to professional fees, public listing and registration fees, and $986 in interest expense.decreased sales, net of higher than usual trade spending .

 

Total operating expenses were $4,306 for the three months ended June 30, 2018 compared to $2,060 for the three months ended June 30, 2017. The 109% increase was primarily attributable to audit and review service fees of $2,000 and increases in professional fees of $2,000.

 

Interest expense costs were $986 for the three months ended June 30, 2018 compared to $548 for the three months ended June 30, 2017. The amount relates to interests on continued related party loans as well as interest accretion on convertible loans.

 Page 1321 

 

 

  Six months ended June 30,     Percent 
  2018  2017  Change  Change 
Revenues $-  $-  $-   -%
Operating expenses  (10,592)  (2,710)  (7,882)  291%
Other expense-interest  (1,981)  (1,090)  (891)  82%
Net loss $(12,573) $(3,800) $(8,773)  231%

Comparison of Nine Months Ended September 30, 2022 to Nine Months Ended September 30, 2021

Results of Operations

  Nine Months ended September 30,     Percent 
  2022  2021  Change  Change 
Revenues $1,468,447  $513,174  $955,273   186% 
Gross profit  764,175   266,867   497,308   186% 
Operating expenses  (2,340,024)  (646,667)  (1,693,360)  315% 
Other income (expense)  (511,450)  (339,111)  (172,339)  51% 
Net loss $(2,087,299) $(718,908) $(1,368,391)  190% 

Net revenues for the nine months ended September 30, 2022 were $1,468,447 as compared to $513,174 for the nine months ended September 30, 2021 which resulted from the merger of HyEdge.

Gross profit for the nine months ended September 30, 2022 was $764,175 as compared to $266,867 for the nine months ended September 30, 2021.

Total operating expenses were $2,340,024 for the nine months ended September 30, 2022 compared to $646,667 for the nine months ended September 30, 2021. The 315% increase was primarily attributable to the additional operating expenses resulting from the merger of HyEdge, specifically $1,087,021 in additional sales and marketing expenses..

Other income (expense) was $(511,450) for the nine months ended September 30, 2022 compared to $(339,111) for the nine months ended September 30,2021. The $172,339 increase was primarily $116,954 decrease in derivative expenses associated with embedded liabilities in convertible debt and $100,061 increase in interest expenses associated with borrowings.

 

For the sixnine months ended JuneSeptember 30, 2018,2022, the Company reported a net loss of $12,573$2,087,299 as compared to a net loss of $3,800$718,908 for the sixnine months ended JuneSeptember 30, 2017.2021. The 231%$1,368,391 increase in net loss for the sixnine months ended JuneSeptember 30, 20182022 mainly resultedarose from $10,592 in generalhigher sales and administrative expenses relating to professional fees, public listing and registration fees, and $1,981 in interest expense.marketing expenses.

 

Total operating expenses were $10,592 for the six months ended June 30, 2018 compared to $2,710 for the six months ended June 30, 2017. The 231% increase was primarily attributable to expenses from the Company’s edgar service fees of $1,932 relating to SEC filing documents and increases in audit and professional fees of $8,000.

Interest expense costs were $1,981 for the six months ended June 30, 2018 compared to $1,090 for the six months ended June 30, 2017. The amount relates to interests on continued related party loans as well as interest accretion on convertible loans.

Liquidity and Capital Resources

 

As of this date,September 30, 2022, the Company has not started generating revenues from operations and has financed its operations primarily through the issuance of capital stock by way of convertible loans from third party and related party loans.

The Company’s objectives when managing its liquidity and capital resources are to generate sufficienthad $22,036 in cash to fund the Company’s operating and working capital requirements.its operations. The Company reported working capital deficit of $21,976$5,427,155 at JuneSeptember 30, 20182022 as compared to a working capital deficit of $22,902$4,855,836 at December 31, 2017,2021, representing an increase in working capital deficit by $926.$571,320.

 

We hadThe Company does not believe its current cash balance will be sufficient to allow the Company to fund its planned operating activities for the next twelve months. The ability of $0the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it becomes profitable. If the Company is unable to obtain adequate capital, it could be forced to cease operations or substantially curtail some or all of its planned activities. These conditions raise substantial doubt as to the Company's ability to continue as a going concern. The accompanying financial statements do not include any adjustments relating to the recoverability and $0, respectively,classification of recorded assets and classification of liabilities should the Company be unable to continue as of June 30, 2018 and December 31, 2017.  a going concern.

 

As the Company continues to incur losses, achieving profitability is dependent on achieving a level of revenues adequate to support the Company's cost structure. The Company may never achieve profitability, and unless and until it does, the Company will continue to need to raise additional capital. Management intends to fund future operations through additional private or public equity offering and may seek additional capital through arrangements with strategic partners of from other sources. There can be no assurances, however, that additional funding will be available on terms acceptable to the Company, or at all. Any equity financing may be dilutive to existing shareholders, which dilution may be significant depending on the terms of the transactions.

22

Operating Activities:

 

For the sixnine months ended JuneSeptember 30, 2018,2022, net cash flow used forby operating activities was $13,500$(1,448,818) compared to $-0-$(110,800) for the sixnine months ended JuneSeptember 30, 2017.2021. The increases in cash flow used for operating activities for both periods2022 period were primarily due to increases in operating expenditures.expenditures resulting from the HyEdge merger.

 

Investing and Financing Activities:

 

Net cash flows provided by (used) in investing and financing activities for the sixnine months ended JuneSeptember 30, 2018 was an additional borrowing2022 were $1,220,000 from sales of $13,000 from the third party lender added to its existing convertible note,common stock shares compared to zero for the six months ended June$149,000 in proceeds from convertible loans in September 30, 2017.2021.

Liquidity and Capital Resource Measures:

 

The Company’s primary source of liquidity has been from convertible loanssales of its common stock and third party and related partyconvertible loans.

 

Loans and Credit Facilities:Going Concern

 

1. A term loan withThe Company has experienced a balancenet loss and had an accumulated deficit of $57,734 which bears interest at 8% per annum, maturing June$3,861,407 as of September 30, 20202022. These conditions raise substantial doubt about the Company’s ability to continue absent raising sufficient capital to fund continued operations. Management expects to incur additional losses in the foreseeable future and convertiblerecognizes the need to common stock atraise capital to remain viable. The accompanying financial statements do not include any adjustments that might be necessary should the lesser of: (i)Company be unable to continue as a 50% discount to market; and (ii) $0.01 per share.

2. A term loan payable to an officer of $6,525 which is unsecured, 7% interest bearing maturing June 30, 2020.going concern.

 

Transaction with Related Parties:

 

On November 9, 2017, $18,110 of Advances Payable- Officer covering expenses paid for by the company’s president Dawn Cames relating to public listing, legal and audit fees and stock transfer costs, were reimbursed by the 3rd party holder of the Note Payable and added to its Note.None.

Page 14

 

Critical Accounting Policies

 

Our condensedRefer to Note 2 in the Consolidated Financial Statements for a summary of recently adopted and recently issued accounting standards and their related effects or anticipated effects on our consolidated financial statements and accompanying notes have been prepared in accordance with U.S. GAAP. The preparation of these financial statements requires management to make estimates, judgments and assumptions that affect reported amounts of assets, liabilities, revenues and expenses. We continually evaluate the accounting policies and estimates used to prepare the condensed financial statements. The estimates are based on historical experience and assumptions believed to be reasonable under current facts and circumstances. Actual amounts and results could differ from these estimates made by management. Certain accounting policies that require significant management estimates and are deemed critical to our results of operations orand financial position are discussed in our Registration Statement on Form 10-12G/A for the years ended December 31, 2017 and 2016, and Note 1 to the Condensed Consolidated Financial Statements in this Form 10-Q.condition.

 

Off-Balance Sheet Arrangements

 

We did not have any off-balance sheet arrangements that are reasonably likely to have a current or future material effect on our financial condition, revenue or expenses, results of operations, liquidity, capital expenditures or capital resources.

  

Inflation and Changing Prices

We do not believe that inflation nor changing prices for the three months September 30, 2022 had a material effect on our operations.

 Page 1523 

 

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

As a “smaller reporting company” as defined by Item 10 of Regulation S-K, we are not required to provide information required by this Item.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

We maintain disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) that are designed to ensure that information required to be disclosed in our reports filed under the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Accounting Officer, as appropriate to allow timely decisions regarding required disclosure.

  

We carried out an evaluation under the supervision and with the participation of management, including our Chief Executive Officer and Chief Accounting Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of JuneSeptember 30, 2018,2022, the end of the period covered by this report. Based on that evaluation, our Chief Executive Officer and Chief Accounting Officer concluded that our disclosure controls and procedures were not effective at the reasonable assurance level due to the material weaknesses discussed below.

 

Internal Control Over Financial Reporting

 

Evaluation of Disclosure Controls and Procedures

 

Management of the Company has evaluated, with the participation of the Chief Executive Officer and Chief Financial Officer of the Company, the effectiveness of the Company's disclosure controls and procedures (as defined in Rules 13a-15(e) or 15d-15(e) promulgated by the Securities and Exchange Commission pursuant to the Securities Exchange Act of 1934, as amended (the "Exchange Act")) as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer of the Company had concluded that the Company's disclosure controls and procedures as of the period covered by this Quarterly Report on Form 10-Q were not effective for the following reasons:

 

a) The Company has limited segregation of duties amongst its employees with respect to the Company's control activities. This deficiency is the result of the Company's limited number of employees. This deficiency may affect management's ability to determine if errors or inappropriate actions have taken place. Management is required to apply its judgment in evaluating the cost-benefit relationship of possible changes in our disclosure controls and procedures.

 

b) The Company's has a limited number of external board members. This deficiency may give the impression to the investors that the board is not independent from management. Management and the Board of Directors are required to apply their judgment in evaluating the cost-benefit relationship of possible changes in the organization of the Board of Directors.

 

Changes in internal control over financial reporting.

 

Management of the Company has also evaluated, with the participation of the Chief Executive Officer of the Company, any change in the Company’s internal control over financial reporting that occurred during the period covered by this AnnualQuarterly Report on Form 10-K10-Q and determined that there was no change in the Company’s internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

 Page 1624 

 

PART II. OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

From time to time, we may be involved in various claims and legal actions in the ordinary course of business. We are not currently involved in any material legal proceedings outside the ordinary course of our business.

 

ITEM 1A. RISK FACTORS

 

As of the date of this report, there have been no material changes to the Risk Factors disclosed in our Registration StatementAnnual Report on Form 10-12G/A10-K for the yearsyear ended December 31, 2017 and 2016.2021.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

NoneOn or about August 8, 2021 the Company issued 30,197,888 shares of Company common stock and 1,003,054 Preferred stock upon the closing of the HyEdge, Inc. acquisition. The shares were the component of the consideration paid by the Company to acquire HyEdge. These shares of Company common stock were offered and sold in a private transaction in accordance with Section 4(a)(2) of the Securities Act of 1933, as amended.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.The Company is in fault on the following notes with due dates on principal and interest as of September 30, 2022:

Lender Principal  Maturity Dates
(a)   Boot Capital LLC $250,000  May 27, 2022
(b)   Boot Capital LLC $152,000  July 22, 2022
(b)   Saliam Inc. $69,309  May 01, 2022
(c)   R. Propper $445,116  July 01,2022
(d)   L. Klingbaum $100,000  July 01, 2022
(e)   C. Leman $90,000  June 30, 2022

The Company is currently pursuing discussions with the above note holders for their extension.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5. OTHER INFORMATION

 

None.

 

 Page 1725 

 

 

ITEM 6. EXHIBITS, FINANCIAL STATEMENT SCHEDULES

 

Exhibits

Filed

Herewith (*)

Incorporated by Reference
Exhibit No.DescriptionFiling TypeDate Filed
2.1Merger Agreement8-K08/11/2021
3.1Articles of Incorporation10-12G01/24/2018
3.2Amendment to Articles of Incorporation8-K08/11/2021
3.3Bylaws10-12G01/24/2018
3.4Amendment to Articles of Incorporation8-K11/18/2021
4.1Series C Preferred Stock Designation8-K08/11/2021
4.2Series D Preferred Stock Designation8-K08/11/2021
10.01Boot Capital Securities Purchase Agreement dated May 27, 20218-K06/10/2021
10.02Boot Capital Convertible Promissory Note dated May 27, 20218-K06/10/2021
10.03Boot Capital Warrant dated May 27, 20218-K06/10/2021
10.04Boot Capital Securities Purchase Agreement dated July 22, 20218-K08/11/2021
10.05Boot Capital Convertible Promissory Note dated July 22, 20218-K08/11/2021
10.06Boot Capital Warrant dated July 22, 20218-K08/11/2021
10.07Boot Capital Securities Purchase Agreement dated October 4, 20218-K10/12/2021
10.08Boot Capital Convertible Promissory Note dated October 4, 20218-K10/12/2021
10.09Boot Capital Warrant dated October 4, 20218-K10/12/2021
10.10IP Assignment Agreement dated July 22, 2022* 
31.1Certification pursuant to Section 302 of the Sarbanes-OxleySarbanes–Oxley Act of 2002.2002 of Principal Executive Officer*
32.131.2Certification pursuant to Section 302 of the Sarbanes–Oxley Act of 2002 of Principal Financial Officer*
32.1Certification pursuant to Section 906 of the Sarbanes-OxleySarbanes–Oxley Act of 2002.2002 of the Principal Executive and Principal Financial Officer*
101*101.INSThe following financial information from the Quarterly Report on Form 10-Q of Ficaar, Inc. for the quarter ended June 30, 2018, formattedInline XBRL Instances Document*
101.SCHInline XBRL Taxonomy Extension Schema Document*
101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document*
101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document*
101.LABInline XBRL Taxonomy Extension Label Linkbase Document*
101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document*
104Cover Page Interactive Data File (formatted as inline XBRL and contained in XBRL (eXtensible Business Reporting Language): (i) Condensed Consolidated Balance Sheets (ii) Condensed Consolidated Statements of Operations; (iii) Condensed Consolidated Statements of Cash Flows, and (iv) Notes to the Condensed Consolidated Financial Statements.Exhibit 101).*

 

*Filed by amendment.

 

 Page 1826 

 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15 of the Securities Exchange Act, of 1934, the registrant has duly caused this reportReport to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 Ficaar,HFactor, Inc.
(Registrant)
   
Date: October 15, 2018November 21, 2022By:/s/ Dawn Cames
  Dawn Cames Principal Executive Officer
  
/s/ Dawn Cames
Dawn Cames,Principal Executive Officer & Acting Principal Financial and
Accounting Officer

 

 Page 1927